Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.5B | 7.2B | 6.9B | 6.5B |
Cost of revenue | 3.2B | 3.0B | 2.9B | 2.8B |
Gross profit | 4.3B | 4.2B | 4.0B | 3.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 347.6M | 337.4M | 312.1M | 272.9M |
Operating income | 3.8B | 3.8B | 3.6B | 3.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.7B | 3.7B | 3.6B | 3.4B |
Tax provision | 919.5M | 912.7M | 902.7M | 846.2M |
Net income | 2.8B | 2.7B | 2.7B | 2.5B |
Basic EPS | — | 9.4 | 9.2 | 8.6 |
Diluted EPS | — | 9.4 | 9.1 | 8.5 |
Basic average shares | — | 292.6M | 292.5M | 292.5M |
Diluted average shares | — | 292.9M | 295.4M | 294.9M |
EBITDA | 4.1B | 4.0B | 3.7B | 3.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |